Articles written by: Hazel Jackson

Pieris Pharmaceuticals, Inc. (PIRS) Analysts See $-0.15 EPS

Pieris Pharmaceuticals, Inc. (PIRS) Analysts See $-0.15 EPS

Analysts expect Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) to report $-0.15 EPS on March, 8.They anticipate $0.32 EPS change or 188.24 % from last quarter’s $0.17 EPS. After having $-0.11 EPS previously, (more…)

Intec Pharma Ltd. (NTEC) EPS Estimated At $-0.30

Intec Pharma Ltd. (NTEC) EPS Estimated At $-0.30

Analysts expect Intec Pharma Ltd. (NASDAQ:NTEC) to report $-0.30 EPS on March, 8.They anticipate $0.09 EPS change or 23.08 % from last quarter’s $-0.39 EPS. After having $-0.28 EPS previously, Intec Pharma (more…)

Analysts See $0.09 EPS for Atlantic Power Corporation (ATP)

Analysts See $0.09 EPS for Atlantic Power Corporation (ATP)

Analysts expect Atlantic Power Corporation (TSE:ATP) to report $0.09 EPS on March, 7.They anticipate $0.23 EPS change or 164.29 % from last quarter’s $-0.14 EPS. T_ATP’s profit would be $9.75 million (more…)

EPS for Southwestern Energy Company (SWN) Expected At $0.27

EPS for Southwestern Energy Company (SWN) Expected At $0.27

Investors sentiment decreased to 1.08 in Q3 2018. Its down 0.08, from 1.16 in 2018Q2. It dived, as 38 investors sold Southwestern Energy Company shares while 85 reduced holdings. 43 funds opened positions (more…)

Analyst at B.Riley FBR Maintains The Teck Resources Limited (TECK) Buy Rating They’ve Had

Analyst at B.Riley FBR Maintains The Teck Resources Limited (TECK) Buy Rating They’ve Had

Teck Resources Limited (TECK) Rating Reaffirmed This Morning, Tuesday, 19 February, Teck Resources Limited (TECK)‘s Buy rating was kept at B.Riley FBR in an analyst note. Teck Resources Limited (NYSE:TECK) (more…)

EPS for NewLink Genetics Corporation (NLNK) Expected At $-0.34

EPS for NewLink Genetics Corporation (NLNK) Expected At $-0.34

Investors sentiment decreased to 0.69 in Q3 2018. Its down 0.11, from 0.8 in 2018Q2. It dropped, as 22 investors sold NewLink Genetics Corporation shares while 20 reduced holdings. 12 funds opened positions (more…)

Analysts See $-0.70 EPS for Nektar Therapeutics (NKTR)

Analysts See $-0.70 EPS for Nektar Therapeutics (NKTR)

Investors sentiment increased to 1.75 in Q3 2018. Its up 0.62, from 1.13 in 2018Q2. It improved, as 24 investors sold Nektar Therapeutics shares while 82 reduced holdings. 56 funds opened positions while (more…)

Forum Energy Tech (NYSE:FET) “Hold” Rating Reiterated Today By B.Riley FBR; The Target Price per Share is Set to $8

Forum Energy Tech (NYSE:FET) “Hold” Rating Reiterated Today By B.Riley FBR; The Target Price per Share is Set to $8

Investors sentiment decreased to 0.9 in Q3 2018. Its down 0.26, from 1.16 in 2018Q2. It is negative, as 17 investors sold Forum Energy Technologies, Inc. shares while 44 reduced holdings. 18 funds (more…)